Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04172597
Title A Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.